New CLAUDIA system could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels.

Using a machine-learning algorithm, researchers can predict interactions that could interfere with a drug’s effectiveness.

Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.

MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.

MIT and MGH researchers design a local, gel-based drug-delivery platform that may provoke a system-wide immune response to metastatic tumors.

Core-shell structures made of hydrogel could enable more efficient uptake in the body.

The fibers could help with testing treatments for nerve-related pain.

Coupling engineered bacteria with low-power electronics could be highly effective in diagnosis, treatment of bowel diseases.

The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.

MIT Open Learning team awarded NIH grant to provide training in biomedical product development, entrepreneurship, and innovation.